Market Cap
Company ProfileCrism Therapeutics Corporation Market Cap History
Market Cap: £7.5 Million
GBP as of Aug 2, 2026 | US$10.1 Million
Company Profile $CRTXCrism Therapeutics Corporation Market Capitalization Over Time
Evolution of Crism Therapeutics Corporation market cap history
Market capitalizations are calculated from the opening stock price at the beginning of each month.
Top Competitors by Market Capitalization
Industry: Biotechnology
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $209.25 B |
| Vertex Pharmaceuticals | $121.09 B |
| Regeneron Pharmaceuticals | $78.52 B |
| argenx | $52.93 B |
| Beigene Ltd. | $51.33 B |
Sector: Healthcare
| Company | Market Cap (USD) |
|---|---|
| Lilly | $1.024 T |
| Johnson & Johnson | $617.78 B |
| AbbVie | $443.36 B |
| Roche | $418.93 B |
| UnitedHealth Group | $376.34 B |
Yearly Market Cap Evolution
| Date | Market Cap | YoY Change |
|---|
Market capitalization is calculated from the opening stock price at the beginning of each year.
Company Description
ProfileCrism Therapeutics Corporation is a clinical-stage biopharmaceutical company focused on discovering and developing innovative gene-based medicines. The company's primary function is to harness the potential of a proprietary technology platform to create transformative therapies for serious diseases. Crism Therapeutics targets key areas such as genetic disorders, hemophilia, and other hematologic conditions, aiming to improve patient outcomes through precision medicine. The asset has a significant presence in the biotechnology sector, impacting areas of health technology and pharmaceuticals. As a pioneer in gene editing techniques, Crism Therapeutics plays a crucial role in advancing scientific research and development within the medical community. Its commitment to innovation makes it a critical player in the broader market, driving innovation and expanding treatment possibilities in clinically unmet needs.
Stocks & Indexes
Crism Therapeutics Corporation main stocks and indexes inclusions.
$CRTXFTSE AIM All-Share
What is Market Capitalization?
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.